nagi bioscience
The company provides an automated in vivo testing platform called SydLab One that uses C. elegans (organism-on-chip technology) to measure lifespan, healthspan, and biological age. They offer both laboratory hardware and contract research services to biotech, nutraceutical, and pharmaceutical companies for drug discovery, toxicity testing, and longevity research. Their technology serves as a New Approach Methodology (NAM) to provide high-throughput data for substance testing without the ethical hurdles of traditional animal models.
Funding summary
- Total raised
- €1.7M
- Funding rounds
- 1
Investors in nagi bioscience
Investors on record for nagi bioscience. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like nagi bioscience?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors